Pfizer【PFE】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

29.13

買値

売値

出来高

29,617,612

28.95 日の範囲 29.44

25.20 52 週間の範囲 33.92

時価総額

165.071B

前日終値

29.34

始値

29.36

時刻

29.15

最終取引時間

財務取引量

US$ 860,859,202

VWAP

29.0658

平均取引量 (3 か月)

30,782,348

発行済株式数

5,666,695,064

配当利回り

5.77%

PER

77.99

1 株当たり利益 (EPS)

0.37

歳入

58.5B

純利益

2.12B

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.pfizer.com

本社

New York, New York, USA

設立

Pfizer Inc is listed in the Pharmaceutical Preparations sector of the ニューヨーク証券取引所 with ticker PFE. The last closing price for Pfizer was US$29.34. Over the last year, Pfizer shares have traded in a share price range of US$ 25.20 to US$ 33.92.

Pfizer currently has 5,666,695,064 shares in issue. The market capitalisation of Pfizer is US$166.26 billion. Pfizer has a price to earnings ratio (PE ratio) of 77.99.

全体の流れ

ベアリッシュ

ネットプレミアム

-2M

Calls / Puts

216.67%

買い / 売り

52.78%

OTM / ITM

58.33%

Sweeps比率

0.00%

Form 4 - Statement of changes in beneficial ownership of securities

U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors

HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis and on-demand treatment in eligible patients with hemophilia A or...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.79	2.78757939308	28.34	30.43	28.34	35806667	29.37133179	CS
4	-0.05	-0.17135023989	29.18	30.43	28.26	29572630	29.27140196	CS
12	-0.74	-2.47740207566	29.87	31.54	27.85	30782348	29.41360527	CS
26	2.78	10.55028463	26.35	31.54	25.2	33921902	28.47046129	CS
52	-4.07	-12.2590361446	33.2	33.92	25.2	37883501	28.38136104	CS
156	-13.31	-31.3619227144	42.44	61.71	25.2	30181763	38.85900722	CS
260	-7.01	-19.3967902601	36.14	61.71	25.2	30150333	38.50519914	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
TCSContainer Store Group Inc	US$ 16.775 (64.95%)	456.98k
WOLFWolfspeed Inc	US$ 11.48 (20.84%)	20.39M
CURVTorrid Holdings Inc	US$ 3.90 (16.07%)	873.1k
NRGVEnergy Vault Holdings Inc	US$ 1.10 (15.78%)	1.44M
AMPXAmprius Technologies Inc	US$ 1.33 (15.65%)	2.48M
SRFMSurf Air Mobility Inc	US$ 2.01 (-38.53%)	2.67M
EBFEnnis Inc	US$ 20.425 (-15.28%)	369.95k
TISITeam Inc	US$ 21.45 (-14.71%)	71.58k
CCMConcord Medical Services Holdings Ltd	US$ 6.49 (-9.61%)	419
CIACitizens Inc	US$ 4.74 (-9.02%)	271.64k
PLTRPalantir Technologies Inc	US$ 43.51 (-0.02%)	64.11M
UBERUber Technologies Inc	US$ 86.34 (10.81%)	54.12M
BACBank of America Corporation	US$ 41.95 (4.95%)	48.06M
NIONIO Inc	US$ 6.245 (0.40%)	40.85M
ALTMArcadium Lithium plc	US$ 5.56 (0.54%)	38.53M